GURDEEP SINGH MD
Prescription History 1982837613
Internal Medicine in Washington, DC


Quality Rating: 81.31 out of 100 score

NPI Status: Active since August 28, 2009

Contact Information

3636 16TH ST NW
WOODNER APARTMENT ,APT NO B 1208
WASHINGTON, DC
ZIP 20010
Phone: (202) 469-2067

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for GURDEEP SINGH MD, an active Internal Medicine specialist practicing in Washington, DC. Our medical registry currently tracks 38 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 2,644 documented patient claims. Among these therapy options, the most frequently utilized medication is Levothyroxine Sodium, which accounts for 858 claims alone.


Alendronate Sodium

Generic Formulation: Alendronate SodiumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 28
30-Day Fills 74.8
Days Supply 2,240
DC State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills68.5
Peer Average Days Supply2,035
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $463.73 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.56

State Avg Cost Per Claim

$13.26

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.

Therapeutic Applications

Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates.

Basaglar Kwikpen U-100

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 27
30-Day Fills 69.8
Days Supply 2,092
DC State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills37.0
Peer Average Days Supply1,024
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 28.6% more claims than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $20,112.94 across this reporting matrix range.

Provider Avg Cost Per Claim

$744.92

State Avg Cost Per Claim

$436.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Bydureon Bcise

Generic Formulation: Exenatide MicrospheresSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 29
30-Day Fills 31.0
Days Supply 874
DC State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills21.9
Peer Average Days Supply628
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 52.6% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $26,673.11 across this reporting matrix range.

Provider Avg Cost Per Claim

$919.76

State Avg Cost Per Claim

$959.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Exenatide is used either alone or with other medications, and with a proper diet and exercise program, to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Exenatide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high sugar (such as after a meal) and decreasing the amount of sugar your liver makes. Exenatide is not a substitute for insulin if you require insulin treatment.

Cabergoline

Generic Formulation: CabergolineSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 21
30-Day Fills 24.8
Days Supply 694
DC State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills40.3
Peer Average Days Supply1,172
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $994.41 across this reporting matrix range.

Provider Avg Cost Per Claim

$47.35

State Avg Cost Per Claim

$86.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE.

Therapeutic Applications

This medication is used to treat high levels of prolactin hormone in your body. High levels of prolactin in women can cause symptoms such as unwanted breast milk and missed periods and can cause difficulty becoming pregnant. High levels of prolactin in men can cause symptoms such as enlarged breasts and decreased sexual ability/desire. Cabergoline is an ergot medication and works by blocking the release of prolactin from the pituitary gland.

Droplet Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 21
30-Day Fills 29.0
Days Supply 810
DC State Average Benchmarks
Peer Average Claims15.0
Peer Average 30-Day Fills20.9
Peer Average Days Supply618
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 40.0% more claims than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,158.94 across this reporting matrix range.

Provider Avg Cost Per Claim

$55.19

State Avg Cost Per Claim

$51.00

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Farxiga

Generic Formulation: Dapagliflozin PropanediolSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 13
30-Day Fills 33.0
Days Supply 990
DC State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills48.2
Peer Average Days Supply1,437
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 51.9% less volume than the regional standard for practitioners inside DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $18,483.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,421.80

State Avg Cost Per Claim

$1,016.20

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used in people with type 2 diabetes and heart disease to lower the risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sugar by your kidneys. Dapagliflozin is also used to treat kidney disease and heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sodium by your kidneys.

Glimepiride

Generic Formulation: GlimepirideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 18
30-Day Fills 30.0
Days Supply 876
DC State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills62.0
Peer Average Days Supply1,835
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $79.03 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.39

State Avg Cost Per Claim

$12.33

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Alkaloids derived from TYRAMINE combined with 3,4-dihydroxybenzaldehyde via a norbelladine pathway, including GALANTAMINE, lycorine and crinine. They are found in the AMARYLLIDACEAE plant family.

Therapeutic Applications

Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Glipizide

Generic Formulation: GlipizideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 15
30-Day Fills 45.0
Days Supply 1,350
DC State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills84.3
Peer Average Days Supply2,475
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 55.9% less volume than the regional standard for practitioners inside DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $313.12 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.87

State Avg Cost Per Claim

$10.08

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.

Therapeutic Applications

Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Humalog Kwikpen U-100

Generic Formulation: Insulin LisproSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 33
30-Day Fills 91.3
Days Supply 2,732
DC State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills46.9
Peer Average Days Supply1,372
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 43.5% more claims than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $39,581.42 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,199.44

State Avg Cost Per Claim

$862.53

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Humulin R U-500 Kwikpen

Generic Formulation: Insulin Regular, HumanSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.0
Days Supply 350
DC State Average Benchmarks
Peer Average Claims15.0
Peer Average 30-Day Fills19.4
Peer Average Days Supply525
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $25,727.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,837.71

State Avg Cost Per Claim

$1,037.18

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin).

Hydrocortisone

Generic Formulation: HydrocortisoneSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 44
30-Day Fills 96.0
Days Supply 2,754
DC State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills31.0
Peer Average Days Supply782
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 76.0% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,294.17 across this reporting matrix range.

Provider Avg Cost Per Claim

$52.14

State Avg Cost Per Claim

$21.85

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.

Therapeutic Applications

Hydrocortisone is a man-made version of a natural substance (cortisol) made by the adrenal gland. This drug is used to treat low cortisol levels caused by diseases of the adrenal gland (such as Addison's disease, adrenocortical insufficiency). Hydrocortisone belongs to a class of drugs known as corticosteroids. Corticosteroids are needed in many ways for the body to function well. They are important for salt and water balance and keeping blood pressure normal.

Insulin Lispro Kwikpen U-100

Generic Formulation: Insulin LisproSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 19
30-Day Fills 47.3
Days Supply 1,418
DC State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills33.5
Peer Average Days Supply906
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,110.65 across this reporting matrix range.

Provider Avg Cost Per Claim

$426.88

State Avg Cost Per Claim

$199.26

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Invokana

Generic Formulation: CanagliflozinSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 22
30-Day Fills 26.0
Days Supply 780
DC State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills26.7
Peer Average Days Supply663
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $15,161.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$689.15

State Avg Cost Per Claim

$745.05

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A glucoside-derived SODIUM-GLUCOSE TRANSPORTER 2 inhibitor that stimulates urinary excretion of glucose by suppressing renal glucose reabsorption. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Canagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Canagliflozin is also used by people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Canagliflozin is also used by people with type 2 diabetes and kidney disease to lower the risk of dialysis, death from heart disease, and the need to go to the hospital for heart failure. Canagliflozin works by increasing the removal of sugar by your kidneys.

Januvia

Generic Formulation: Sitagliptin PhosphateSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 22
30-Day Fills 53.0
Days Supply 1,590
DC State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills54.1
Peer Average Days Supply1,548
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $28,916.55 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,314.39

State Avg Cost Per Claim

$1,011.76

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES.

Therapeutic Applications

Sitagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Sitagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes.

Jardiance

Generic Formulation: EmpagliflozinSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 130
30-Day Fills 199.0
Days Supply 5,922
DC State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills62.6
Peer Average Days Supply1,848
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 306.3% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $122,148.41 across this reporting matrix range.

Provider Avg Cost Per Claim

$939.60

State Avg Cost Per Claim

$1,022.28

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Empagliflozin works by increasing the removal of sodium by your kidneys.

Lantus Solostar

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 68
30-Day Fills 169.4
Days Supply 5,006
DC State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills57.5
Peer Average Days Supply1,685
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 134.5% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $53,243.35 across this reporting matrix range.

Provider Avg Cost Per Claim

$782.99

State Avg Cost Per Claim

$619.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Levemir Flexpen

Generic Formulation: Insulin DetemirSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 26
30-Day Fills 68.1
Days Supply 2,043
DC State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$746.76

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin detemir is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin detemir is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin detemir may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs (such as metformin, exenatide).

Levothyroxine Sodium

Generic Formulation: Levothyroxine SodiumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 858
30-Day Fills 2,227.4
Days Supply 66,376
DC State Average Benchmarks
Peer Average Claims57.0
Peer Average 30-Day Fills140.3
Peer Average Days Supply4,126
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 1,405.3% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $18,413.29 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.46

State Avg Cost Per Claim

$19.59

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

Therapeutic Applications

Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.

Liothyronine Sodium

Generic Formulation: Liothyronine SodiumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 40
30-Day Fills 94.5
Days Supply 2,798
DC State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills55.8
Peer Average Days Supply1,668
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 73.9% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,200.59 across this reporting matrix range.

Provider Avg Cost Per Claim

$55.01

State Avg Cost Per Claim

$72.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.

Therapeutic Applications

Liothyronine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally made by the thyroid gland. Liothyronine is a man-made form of thyroid hormone. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone helps you stay healthy. For children, having enough thyroid hormone helps them grow and learn normally. This medication is also used to treat other types of thyroid problems (such as certain types of goiters, thyroid cancer). It can also be used to test for certain types of thyroid disease. This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.

Metformin Hcl

Generic Formulation: Metformin HclSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 191
30-Day Fills 435.7
Days Supply 13,018
DC State Average Benchmarks
Peer Average Claims54.0
Peer Average 30-Day Fills126.1
Peer Average Days Supply3,718
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 253.7% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,428.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.71

State Avg Cost Per Claim

$9.09

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

Therapeutic Applications

Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb.

Metformin Hcl Er

Generic Formulation: Metformin HclSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 112
30-Day Fills 294.0
Days Supply 8,774
DC State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills79.3
Peer Average Days Supply2,366
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 261.3% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,928.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.22

State Avg Cost Per Claim

$12.24

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

Therapeutic Applications

Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb.

Methimazole

Generic Formulation: MethimazoleSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 133
30-Day Fills 329.0
Days Supply 9,858
DC State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills63.8
Peer Average Days Supply1,851
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 375.0% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,006.98 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.09

State Avg Cost Per Claim

$14.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme.

Therapeutic Applications

Methimazole is used to treat overactive thyroid (hyperthyroidism). It works by stopping the thyroid gland from making too much thyroid hormone.

Nano 2nd Gen Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 31
30-Day Fills 89.3
Days Supply 2,675
DC State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills51.3
Peer Average Days Supply1,511
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,909.51 across this reporting matrix range.

Provider Avg Cost Per Claim

$126.11

State Avg Cost Per Claim

$87.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Novolog Flexpen

Generic Formulation: Insulin AspartSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 81
30-Day Fills 184.8
Days Supply 5,529
DC State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills46.2
Peer Average Days Supply1,328
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 224.0% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $107,990.03 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,333.21

State Avg Cost Per Claim

$912.26

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

Therapeutic Applications

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

Omnipod 5 G6 Pods (Gen 5)

Generic Formulation: Insulin Pump Cart,automated,btSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 360
DC State Average Benchmarks
Peer Average Claims13.0
Peer Average 30-Day Fills29.0
Peer Average Days Supply870
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,149.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$595.77

State Avg Cost Per Claim

$1,736.52

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Ozempic

Generic Formulation: SemaglutideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 172
30-Day Fills 288.6
Days Supply 8,456
DC State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills47.1
Peer Average Days Supply1,381
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 473.3% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $277,953.31 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,616.01

State Avg Cost Per Claim

$1,467.92

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment.

Steglatro

Generic Formulation: Ertugliflozin PidolateSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 354
DC State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$369.63

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Ertugliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Ertugliflozin works by increasing the removal of sugar by your kidneys.

Synjardy

Generic Formulation: Empagliflozin/Metformin HclSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 11
30-Day Fills 13.0
Days Supply 390
DC State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills37.9
Peer Average Days Supply1,130
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,965.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$724.11

State Avg Cost Per Claim

$1,010.22

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is a combination of 2 drugs: empagliflozin and metformin. It is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication works by helping to restore your body's proper response to the insulin you naturally produce. It also increases the removal of sugar by your kidneys, decreases how much sugar is made in your liver, and decreases how much sugar your body takes in through your stomach and intestines.

Synthroid

Generic Formulation: Levothyroxine SodiumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 139
30-Day Fills 397.3
Days Supply 11,920
DC State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills98.1
Peer Average Days Supply2,936
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 286.1% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $12,740.76 across this reporting matrix range.

Provider Avg Cost Per Claim

$91.66

State Avg Cost Per Claim

$95.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

Therapeutic Applications

Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.

Testosterone

Generic Formulation: TestosteroneSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 28
30-Day Fills 58.3
Days Supply 1,720
DC State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills34.6
Peer Average Days Supply1,017
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 27.3% more claims than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $17,235.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$615.57

State Avg Cost Per Claim

$339.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.

Therapeutic Applications

This medicated patch contains testosterone. It is used for hormone replacement in men who are not able to produce enough testosterone (for example, due to hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels. Testosterone helps the body to develop and maintain the male sexual characteristics (masculinity), such as a deep voice and body hair. It also helps to maintain muscle and prevent bone loss, and is necessary for natural sexual ability/desire. This drug should not be used by women.

Testosterone Cypionate

Generic Formulation: Testosterone CypionateSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 44
30-Day Fills 83.9
Days Supply 2,485
DC State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills27.4
Peer Average Days Supply793
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 144.4% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,795.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$40.82

State Avg Cost Per Claim

$55.62

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used in men who do not make enough of a natural substance called testosterone. In males, testosterone is responsible for many normal functions, including growth and development of the genitals, muscles, and bones. It also helps cause normal sexual development (puberty) in boys. Testosterone belongs to a class of drugs known as androgens. It works by affecting many body systems so that the body can develop and function normally. Testosterone may also be used in certain adolescent boys to cause puberty in those with delayed puberty. It may also be used to treat certain types of breast cancer in women.

Tresiba Flextouch U-100

Generic Formulation: Insulin DegludecSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 26
30-Day Fills 49.2
Days Supply 1,439
DC State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills47.5
Peer Average Days Supply1,418
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 30.0% more claims than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $26,050.52 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,001.94

State Avg Cost Per Claim

$747.37

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

Tresiba Flextouch U-200

Generic Formulation: Insulin DegludecSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 26
30-Day Fills 58.1
Days Supply 1,722
DC State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills57.0
Peer Average Days Supply1,647
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $41,063.10 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,579.35

State Avg Cost Per Claim

$1,064.91

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

Trulicity

Generic Formulation: DulaglutideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 71
30-Day Fills 105.6
Days Supply 3,064
DC State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills55.0
Peer Average Days Supply1,597
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 91.9% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $105,045.19 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,479.51

State Avg Cost Per Claim

$1,418.91

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment.

Ultra-Fine Mini Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 27
30-Day Fills 59.0
Days Supply 1,760
DC State Average Benchmarks
Peer Average Claims15.0
Peer Average 30-Day Fills29.8
Peer Average Days Supply883
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 80.0% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,153.42 across this reporting matrix range.

Provider Avg Cost Per Claim

$116.79

State Avg Cost Per Claim

$82.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Ultra-Fine Nano Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 19
30-Day Fills 48.2
Days Supply 1,445
DC State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills40.0
Peer Average Days Supply1,172
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,509.74 across this reporting matrix range.

Provider Avg Cost Per Claim

$132.09

State Avg Cost Per Claim

$85.57

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Unifine Pentips

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 15
30-Day Fills 44.0
Days Supply 1,321
DC State Average Benchmarks
Peer Average Claims15.0
Peer Average 30-Day Fills24.0
Peer Average Days Supply699
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $802.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$53.49

State Avg Cost Per Claim

$45.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Victoza 3-Pak

Generic Formulation: LiraglutideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 46
30-Day Fills 85.0
Days Supply 2,550
DC State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills29.9
Peer Average Days Supply898
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 119.0% higher than the standard regional baseline profile for DC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $96,371.29 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,095.03

State Avg Cost Per Claim

$1,495.23

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN.

Therapeutic Applications

This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like GURDEEP SINGH MD provides transparency into local medical care patterns within Washington, DC.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Internal Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.